NLRP3 and COVID-19: Although SARS-CoV-2 infection triggers activation of the NLRP3 inflammasome that results in tissue damage and severe COVID-19 (Freeman and Swartz, 2020; van den Berg and Te Velde, 2020), it is unclear at present whether ORF3a is directly involved in activating the NLRP3 inflammasome.